![A line drawing of a laptop and a cup of coffee](/sites/default/files/2020-12/hero-laptop.png)
Substance Abuse and Mental Health Services Administration (SAMHSA)
Substance Abuse and Mental Health Services Administration (SAMHSA)
Articles in this supplement focus on the global opioid crisis, including coverage of harm reduction approaches, health justice promotion, and lessons learned.
This month, the Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA), announced three funding opportunities to strengthen mental health and substance use systems and services for people with or affected by HIV:
This guide offers considerations for how state agency staff can develop and maintain an accessible, HIV and opioid use disorder (OUD) service inventory. This guide can be used by state agency HIV and OUD staff to:
Because of naloxone’s ability to reverse opioid overdose and its ease of use, by July 15, 2017, all 50 states and the District of Columbia had passed legislation to improve naloxone access, as one strategy to reduce opioid overdose morbidity and mortality.
This webinar companion guide provides information for the January 2021 Strengthening Systems of Care: Supporting People with HIV and Opioid Use Disorder following Incarceration webinar.
This Advisory highlights strategies and considerations for substance use disorder (SUD) treatment providers to integrate HIV services into their practice and effectively engage people with HIV in SUD treatment.
This technical package, a collaborative effort between CDC and NASTAD, provides a broad framework as well as evidence-informed strategies and approaches to support the planning, design, implementation, and sustainability of new and existing syringe services programs (SSPs).
This publication, part of SAMHSA's Evidence Based Resource Guide series, addresses the co-occurrence of HIV and mental illness and/or SUD.